— Know what they know.
Not Investment Advice

KZIA Earnings

Kazia Therapeutics Ltd ADR
1W: -3.1% 1M: -26.5% 3M: -29.1% YTD: +85.4% 1Y: +35.3% 3Y: -82.0% 5Y: -98.3%
$9.27
-0.20 (-2.11%)
 
Weekly Expected Move ±9.3%
$8 $8 $9 $10 $11
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $15.0M mcap · 2M float · 15.18% daily turnover · Short 50% of daily vol
Last Earnings 2026-09-04
EPS
A$-0.60 (US$-0.42)
▲ Beat +0.9%
Revenue
A$183K ($128K)
▼ Miss -62.5%

Estimate vs Actual

Earnings Surprise History

2/20
EPS Beats
2/20
Revenue Beats
10%
EPS Beat Rate
10%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-25 annual 2027-06-30 A$-1.48 A$-1.48 — A$580,248 A$580,248
2026-09-21 annual 2029-06-30 A$-1.26 A$-2.54 ▼ 1.28 A$35,200,689 A$1,196,684
2026-09-21 annual 2030-06-30 A$0.27 A$-2.52 ▼ 2.79 A$63,561,624 A$13,368,665
2026-09-11 annual 2031-06-30 A$2.25 A$-1.54 ▼ 3.79 A$129,445,950 A$40,156,244
2026-09-11 annual 2027-06-30 A$-1.37 A$-1.48 ▼ 0.11 A$574,229 A$580,248
2026-09-11 annual 2030-06-30 A$1.53 A$0.27 ▼ 1.26 A$91,623,573 A$63,561,624
2026-09-11 annual 2028-06-30 A$-1.80 A$-2.04 ▼ 0.24 A$1,116,258 A$1,127,958
2026-09-11 annual 2029-06-30 A$-1.00 A$-1.26 ▼ 0.26 A$32,770,555 A$35,200,689
2026-09-07 annual 2031-06-30 A$— A$2.25 ▲ 2.25 A$— A$129,445,950
2026-09-04 annual 2030-06-30 A$1.53 A$1.53 — A$91,623,660 A$91,623,573
2026-09-04 annual 2027-06-30 A$-1.37 A$-1.37 — A$574,309 A$574,229
2026-09-04 annual 2028-06-30 A$-1.81 A$-1.80 ▲ 0.01 A$1,116,456 A$1,116,258
2026-09-04 annual 2026-06-30 A$-1.33 A$-1.33 — A$476,635 A$476,550
2026-09-04 annual 2029-06-30 A$-1.00 A$-1.00 — A$32,770,659 A$32,770,555
2026-09-03 annual 2030-06-30 A$1.49 A$1.53 ▲ 0.04 A$90,697,730 A$91,623,660
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms